These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 17217402)
1. Oral pharmacokinetic and pharmacodynamic effects of FTY720 in cats. Downes S; Chen YJ; Kyles A; Gregory C J Vet Pharmacol Ther; 2007 Feb; 30(1):55-61. PubMed ID: 17217402 [TBL] [Abstract][Full Text] [Related]
2. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Mehling M; Brinkmann V; Antel J; Bar-Or A; Goebels N; Vedrine C; Kristofic C; Kuhle J; Lindberg RL; Kappos L Neurology; 2008 Oct; 71(16):1261-7. PubMed ID: 18852441 [TBL] [Abstract][Full Text] [Related]
3. Multiple-dose FTY720: tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects. Kovarik JM; Schmouder R; Barilla D; Riviere GJ; Wang Y; Hunt T J Clin Pharmacol; 2004 May; 44(5):532-7. PubMed ID: 15102874 [TBL] [Abstract][Full Text] [Related]
4. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Hofmann M; Brinkmann V; Zerwes HG Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343 [TBL] [Abstract][Full Text] [Related]
5. FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction. Kovarik JM; Schmouder RL; Barilla D; Büche M; Rouilly M; Berthier S; Wang Y; Van Saders C; Mayer T; Gottlieb AB Ann Pharmacother; 2004; 38(7-8):1153-8. PubMed ID: 15138297 [TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of the effect of a novel immunosuppressive agent, FTY720, on the function of feline neutrophils. Chen YJ; Kyles AE; Gregory CR Am J Vet Res; 2006 Apr; 67(4):588-92. PubMed ID: 16579750 [TBL] [Abstract][Full Text] [Related]
7. Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses. Meno-Tetang GM; Li H; Mis S; Pyszczynski N; Heining P; Lowe P; Jusko WJ Drug Metab Dispos; 2006 Sep; 34(9):1480-7. PubMed ID: 16751263 [TBL] [Abstract][Full Text] [Related]
13. Oral-intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effects. Kovarik JM; Hartmann S; Bartlett M; Riviere GJ; Neddermann D; Wang Y; Port A; Schmouder RL Biopharm Drug Dispos; 2007 Mar; 28(2):97-104. PubMed ID: 17230596 [TBL] [Abstract][Full Text] [Related]
14. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. Foster CA; Howard LM; Schweitzer A; Persohn E; Hiestand PC; Balatoni B; Reuschel R; Beerli C; Schwartz M; Billich A J Pharmacol Exp Ther; 2007 Nov; 323(2):469-75. PubMed ID: 17682127 [TBL] [Abstract][Full Text] [Related]
15. A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments. Suzuki T; Jin MB; Shimamura T; Yamashita K; Taniguchi M; Nomura M; Yokota R; Fukai M; Magata S; Horiuchi H; Fujita M; Nagashima K; Furukawa H; Todo S Transpl Int; 2004 Nov; 17(10):574-84. PubMed ID: 15592714 [TBL] [Abstract][Full Text] [Related]
16. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice. Liu L; Wang C; He X; Shang W; Bi Y; Wang D Microsurgery; 2007; 27(4):300-4. PubMed ID: 17477424 [TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. Budde K; L Schmouder R; Nashan B; Brunkhorst R; W Lücker P; Mayer T; Brookman L; Nedelman J; Skerjanec A; Böhler T; Neumayer HH Am J Transplant; 2003 Jul; 3(7):846-54. PubMed ID: 12814476 [TBL] [Abstract][Full Text] [Related]
18. Prolonged administration of FTY720 does not cause renal toxicity in mice. Galvão VR; Ginoza M; Franco M; Burdmann EA; Bueno V Transplant Proc; 2005; 37(1):112-3. PubMed ID: 15808564 [TBL] [Abstract][Full Text] [Related]
19. Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice. Lopes CT; Gallo AP; Palma PV; Cury PM; Bueno V Transplant Proc; 2008 Apr; 40(3):856-60. PubMed ID: 18455036 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques. Kersh EN; Luo W; Adams DR; Mitchell J; Garcia-Lerma JG; Butera S; Folks T; Otten R J Antimicrob Chemother; 2009 Apr; 63(4):758-62. PubMed ID: 19218272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]